Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 Dicembre;52(4) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 Dicembre;52(4):369-77

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

REVIEWS  MIBG IN DIAGNOSIS AND THERAPY


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 Dicembre;52(4):369-77

lingua: Inglese

Cardiac 123I-MIBG scintigraphy in heart failure

Agostini D. 1, Verberne H. J. 2, Hamon M. 1, Jacobson A. F. 3, Manrique A. 1

1 CHU Cote de Nacre, Caen, France
2 Academic Medical Center University of Amsterdam, Amsterdam, The Netherlands
3 GE Healthcare, Princeton, NJ, USA


FULL TEXT  ESTRATTI


This review focuses on myocardial [123I]mIBG imaging in patients with cardiomyopathy and heart failure (HF). In particular, the potential role of myocardial 123I-mIBG scintigraphy in the prediction of potentially fatal arrhythmic events is described. A growing body of evidence supports the use of cardiac sympathetic innervation imaging, specifically using 123I-mIBG, to risk stratify patients with HF. Cardiac sympathetic imaging can help to improve understanding of the mechanisms responsible for increased sympathetic activity in HF, and how sympathetic over-activity exerts its deleterious actions. Eventually, this may result in more effective therapies and, thereby, better outcome for these patients. Assessment of cardiac sympathetic activity could also contribute to a more appropriate selection of individual patients for implantable cardioverter-defibrillators (ICD).

inizio pagina